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Abstract
Background: The molecular structure of Fasciola gigantica 14-3-3 protein has been characterized. However, the
involvement of this protein in parasite pathogenesis remains elusive and its effect on the functions of innate
immune cells is unknown. We report on the cloning and expression of a recombinant F. gigantica 14-3-3 epsilon
protein (rFg14-3-3e), and testing its effects on specific functions of goat peripheral blood mononuclear cells
(PBMCs).
Methods: rFg14-3-3e protein was expressed in Pichia pastoris. Western blot and immunofluorescence assay (IFA)
were used to examine the reactivity of rFg14-3-3e protein to anti-F. gigantica and anti-rFg14-3-3e antibodies,
respectively. Various assays were used to investigate the stimulatory effects of the purified rFg14-3-3e protein on
specific functions of goat PBMCs, including cytokine secretion, proliferation, migration, nitric oxide (NO) production,
phagocytosis, and apoptotic capabilities. Potential protein interactors of rFg14-3-3e were identified by querying the
databases Intact, String, BioPlex and BioGrid. A Total Energy analysis of each of the identified interaction was
performed. Gene Ontology (GO) enrichment analysis was conducted using Funcassociate 3.0.
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Results: Sequence analysis revealed that rFg14-3-3e protein had 100% identity to 14-3-3 protein from Fasciola
hepatica. Western blot analysis showed that rFg14-3-3e protein is recognized by sera from goats experimentally
infected with F. gigantica and immunofluorescence staining using rat anti-rFg14-3-3e antibodies demonstrated the
specific binding of rFg14-3-3e protein to the surface of goat PBMCs. rFg14-3-3e protein stimulated goat PBMCs to
produce interleukin-10 (IL-10) and transforming growth factor beta (TGF-β), corresponding with low levels of IL-4
and interferon gamma (IFN-γ). Also, this recombinant protein promoted the release of NO and cell apoptosis, and
inhibited the proliferation and migration of goat PBMCs and suppressed monocyte phagocytosis. Homology
modelling revealed 65% identity between rFg14-3-3e and human 14-3-3 protein YWHAE. GO enrichment analysis of
the interacting proteins identified terms related to apoptosis, protein binding, locomotion, hippo signalling and
leukocyte and lymphocyte differentiation, supporting the experimental findings.
Conclusions: Our data suggest that rFg14-3-3e protein can influence various cellular and immunological functions
of goat PBMCs in vitro and may be involved in mediating F. gigantica pathogenesis. Because of its involvement in F.
gigantica recognition by innate immune cells, rFg14-3-3e protein may have applications for development of
diagnostics and therapeutic interventions.
Keywords: Fasciola gigantica, 14-3-3 epsilon protein isoform, Homology modelling, Goat, Peripheral blood
mononuclear cells
Background
Fasciola gigantica is a worldwide distributed liver fluke
that can infect a wide range of livestock of economic im-
portance such as cattle, sheep and goats [1]. Infections
with Fasciola spp. result in reduced meat, milk and wool
production [2], with an estimated economic loss more
than 3 billion USD per annum worldwide [3, 4]. In
addition, disease caused by Fasciola infection (known as
fasciolosis) in humans is included in the WHO top listed
neglected tropical diseases [5, 6], and it is estimated that
at least 2.4 million people are infected worldwide and
180 million are at risk of infections [2].
The mammalian definitive hosts of F. gigantica be-
come infected by ingestion of vegetation containing
encysted metacercariae. Infective metacercariae emerge
in the duodenum, rapidly traverse the intestinal wall,
and migrate through the peritoneal cavity to reach the
liver capsule. Following a period of burrowing, feeding
and growth within the liver parenchyma, the flukes
reach their final destination within the bile ducts where
they attain their sexual maturity and produce eggs [7, 8].
During their migration and development, liver flukes en-
counter various host tissue types, distinct physiological
microenvironments, and a combination of both humoral
and cellular immune responses. F. gigantica can remark-
ably tackle these challenges and survive for extended pe-
riods inside its host [9].
Although host immune evasion is a common strategy
used by successful parasites, Fasciola spp. provoke rec-
ognition by host immune cells less capable of destroying
them. To accomplish this, they use virulence-associated
excretory-secretory products (ESPs) to manipulate cellu-
lar processes [10], such as immune evasion and immune
subversion [11, 12] to promote parasite survival. Among
the virulence factors in the ESPs that are involved in
host-parasite interaction, the 14-3-3 proteins are of in-
terests given their ability to bind to many signaling pro-
teins, such as kinases and phosphatases, and to mediate
many regulatory processes, metabolism and signal trans-
duction pathways [13, 14]. The 14-3-3 family encom-
passes a group of conserved intracellular polypeptides
with molecular weight of 28–33 kDa, which are found in
all eukaryotic organisms [15]. These proteins have been
the focus of much research due to their roles in modu-
lating various protein-protein interactions [16, 17].
Various structural and functional aspects of 14-3-3
protein have been studied in Toxoplasma gondii [18],
Schistosoma japonicum [19], Eimeria tenella [20],
Echinococcus granulosus [21], Haemonchus contortus
[22] and Trichinella spiralis [23], and the putative
role of 14-3-3 protein in parasite pathogenesis has
been reported [24–27]. However, the biological effects
of F. gigantica 14-3-3 protein on the host innate im-
mune system are still largely unknown.
In the present study, the gene encoding F. gigantica
14-3-3 epsilon protein (Fg14-3-3e) isoform was cloned
and expressed in Pichia pastoris. The modulatory ef-
fects of the purified rFg14-3-3e on various functions
of the goat peripheral blood mononuclear cells
(PBMCs), including cytokine secretion, proliferation,
migration, nitric oxide (NO) production, phagocytosis
and apoptosis were studied using a range of assays.
These experimental studies were complemented by in
silico homology modelling analysis. Our data suggest
that rFg14-3-3e protein can significantly influence the
cellular and immunological functions of goat PBMCs,
all critical pieces of the immunopathogenesis of F.
gigantica infection.
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Methods
Animals used in the experiments
Local, 3- to 6-month-old crossbred goats were obtained
from the teaching and research flock at Nanjing Agricul-
tural University. Goats were fed with hay and whole
shelled corn, and were housed indoor in pens and pro-
vided with water ad libitum. All goats were treated with
triclabendazole (50 mg/kg body weight) in order to elim-
inate any potential previous infection with Fasciola spp.
A fecal sample from each goat was microscopically ex-
amined for helminth eggs 2 weeks after treatment. Only
goats demonstrating no eggs were included in the study
and daily health checks were performed throughout the
experiment. Three biological replicates (three goats),
each consisting of three technical replicates (i.e. three
samples from each goat), were used in this study. For
the production of antibodies, female Sprague Dawley
(SD) rats (body weight ~150 g) were purchased from the
Experimental Animal Center of Jiangsu, PR China
(Qualified Certificate: SCXK 2008-0004) and were
housed under specific-pathogen-free conditions in the
lab animal facility and fed sterilized food and water ad
libitum. All efforts were made to minimize suffering of
animals.
Isolation of goat PBMCs
Goat peripheral venous blood samples were collected
from healthy goats. The goat PBMCs were isolated from
freshly collected blood samples using commercially
available goat PBMCs’ isolation kit (TBD, Tianjin,
China). The number of goat PBMCs were adjusted to a
density of 1 × 106 cells/ml in RPMI 1640 medium con-
taining 10% fetal bovine serum (FBS), 1% penicillin-
streptomycin (Gibco, New York, USA). Goat PBMCs
were maintained in a humidified atmosphere of 5%
CO2 at 37 °C. Cells viability was determined by try-
pan blue dye exclusion, and only cells with more than
95% viability were used in the experiments. Mono-
cytes were isolated from goat PBMCs based on their
tendency to adhere to the plastic surface of the cell
culture flasks [28].
Parasite strain
Adult flukes of F. gigantica were collected from the gall-
bladder of naturally infected buffaloes slaughtered for
human consumption at local abattoirs in Guangxi
Zhuang Autonomous Region, PR China. After washing
in phosphate buffered saline (PBS, pH 7.4), the flukes
were collected and immediately used for RNA isolation
or stored at -80 °C with RNA stabilizer until use. The
species identity was confirmed as F. gigantica based on
PCR and sequencing of the second internal transcribed
spacer (ITS2) of ribosomal DNA [29], which yielded ab-
solute homology to ITS2 sequence of F. gigantica from
Guangxi Zhuang Autonomous Region (GenBank:
AJ557569).
Recombinant plasmid construction and sequencing of
Fg14-3-3e gene
Due to the limited genomic data on F. gigantica, we
searched Fasciola hepatica ESPs dataset acquired by li-
quid chromatography-tandem mass spectrometry (LC-
MS/MS) and F. hepatica cDNA library from previous
proteomic studies to screen for homologous 14-3-3 pro-
tein sequences using the BLAST program (https://blas-
t.ncbi.nlm.nih.gov/Blast.cgi). This analysis identified F.
hepatica 14-3-3 epsilon protein isoform (Fh14-3-3e) se-
quence, which was used to design primers to amplify F.
gigantica 14-3-3 epsilon protein isoform (Fg14-3-3e) se-
quence. First-strand cDNA was synthesized from total F.
gigantica RNA, isolated from 30 mg of adult F. gigantica
flukes using Trizol reagent (Invitrogen, San Diego,
USA), by reverse transcription polymerase chain reac-
tion (RT-PCR) using RevertAid First Strand cDNA Syn-
thesis Kit (Thermo Scientific (EU), Vilnius, Lithuania).
The cDNA was used for amplification of Fg14-3-3e gene
using a forward primer (5'-CCG GAA TTC GAG GAG
GTG AAT ATC G-3') and a reverse primer (5'-ATT T G
CGG CCG CCT AAG CCT TTT TCT CCT C-3').
These specific primers of Fg14-3-3e gene were designed
based on the published sequence of Fh14-3-3e gene
(GenBank: LN629113.1). EcoRI and NotI restriction sites,
indicated by underline, were incorporated into the
primers to facilitate cloning. The amplified Fg14-3-3e
gene was digested with EcoRI and NotI and spliced into
the corresponding cloning sites in the plasmid vector
pMD19-T (Takara, Dalian, Liaoning, China). The recom-
binant plasmid was transformed into Trans5α chem-
ically competent cells (TransGen Biotech, Beijing,
China). Several positive clones were selected and se-
quenced by GenScript (Nanjing, Jiangsu, China) to
confirm the correct insertion/orientation of Fg14-3-3e
gene in the vector.
Characterization of the Fg14-3-3e gene sequence
We characterized the Fg14-3-3e gene sequence by trans-
lating the cDNA sequence into the amino acid se-
quences using Seaview [30]. Then, three different
approaches were used to identify and annotate signa-
tures of functional mechanisms present in the amino
acidic sequence. Specifically, the protein sequence was
first subjected to the prediction of sequence domain,
followed by comparative analysis and 3D modelling. The
presence of sequence domain was performed using
SMART (Simple Modular Architecture Research Tool)
[31]. Next, a comparative analysis was done to search for
similarities in protein sequence databases (NCBI non-
redundant protein sequence) and to identify possible
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homologous proteins. Furthermore, we predicted the
three-dimensional model of the homo-dimer using
homology modelling (Swissmodel) [32]. The signal
peptide was predicted by SignalP 4.1 Server (http://
www.cbs.dtu.dk/services/SignalP/), the transmembrane
region was predicted by TMHMM Server v. 2.0 (http://
www.cbs.dtu.dk/services/TMHMM/) and the potential
N-glycosylation sites were predicted by NetNGlyc 1.0 Ser-
ver (http://www.cbs.dtu.dk/services/NetNGlyc/).
Expression of rFg14-3-3e protein
Positive clones, containing the Fg14-3-3e gene in the
correct orientation were selected. The purified Fg14-3-3e
gene fragment was sub-cloned into pPIC9K vector. The
constructs were designed with appropriate restriction
sites and a carboxyl-terminal His6 tag to enable purifica-
tion. The plasmid pPIC9K-Fg14-3-3e was linearized with
SalI to transform the Methylotrophic Yeast P. pastoris
GS115 strain by electroporation using a GenePulser
XcellTM (Bio-Rad, Hercules, California, USA). Positive
recombinant P. pastoris clones containing the insert
were selected for expression by inoculating into 15 ml of
buffered complex medium containing glycerol (BMGY).
The inoculated BMGY medium [1% (wt/vol) yeast ex-
tract, 2% (wt/vol) peptone, 1% (wt/vol) yeast nitrogen
base, 1% (wt/vol) glycerol, 0.00004% (wt/vol) biotin, and
0.1 M potassium phosphate (pH 6.0)] in 100 ml conical
flasks was grown at 28 °C with vigorous shaking for 24
h. The cells were harvested by centrifugation (250× g for
10 min), resuspended in 20 ml of buffered complex
medium containing methanol (BMMY; BMGY medium
with 1% methanol substituted for glycerol). The culture
was allowed to continue growing for four days. During
this Fg14-3-3e gene expression induction period, metha-
nol was added every 24 h to maintain a final concentra-
tion of 1% (v/v). The cells were then pelleted by
centrifugation (2,500× g at 4 °C for 10 min) and the cul-
ture supernatant was harvested for protein extraction. P.
pastoris cells transformed with vector pPIC9K (without
insert) were similarly treated and analyzed as a negative
control.
Protein extraction and SDS-PAGE
Following extraction of the total protein from the yeast
culture supernatant by precipitation with 10%
trichloroacetic acid, the protein pellet was washed sev-
eral times with acetone and finally dissolved in distilled
water. The size of the isolated rFg14-3-3e protein was
analyzed in 12% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gels, followed by Coo-
massie blue staining, and the concentration of the pro-
tein was determined using the Bradford method, using
bovine serum albumin (BSA) as the standard. Purified
proteins were stored frozen in 1× PBS at -80 °C until
further analysis.
Preparation of polyclonal antibodies
Five goats, raised in helminth-free conditions, were in-
fected orally with 500 viable encysted metacercariae per
animal. One month later, the goat antisera were col-
lected and stored frozen in aliquots at -80 °C until use in
Western blot analysis. To generate specific antibodies
against rFg14-3-3e protein, 300 μg of the purified pro-
tein mixed with complete Freund’s adjuvant (1:1) were
injected subcutaneously into SD rats for primary
immunization. SD rats were boosted four times with the
same dose of the recombinant protein in incomplete
Freund’s adjuvant at 2-week intervals. One week after
the last injection, serum containing specific anti-rFg14-
3-3e antibodies was collected and stored frozen at -80 °C
for later use in immunofluorescence visualization of
rFg14-3-3e protein binding to the surface of the goat
PBMCs.
Western blotting
Extracted rFg14-3-3e protein samples (20 μg) were re-
solved on 12% SDS-PAGE gels and transferred onto
Hybond-C extra nitrocellulose membrane (Amersham,
London, UK). Non-specific binding sites were blocked
by immersing the membranes in 5% skim (non-fat) milk
in Tris-buffered saline containing 0.1% Tween-20
(TBST) for 1 h at ambient temperature. The membranes
were then washed 5 times (5 min each) in TBST. Subse-
quently, the membranes were incubated with the pri-
mary antibodies (antiserum from goats experimentally
infected with F. gigantica) for 1 h at 37 °C (1:100 in
TBST). After being washed 5 times with TBST, the
membranes were incubated with HRP-conjugated rabbit
anti-goat IgG (Sigma, St. Louis, MO, USA) for 1 h at 37
°C (1:2000 in TBST). Finally, the immunoreaction was
visualized using freshly prepared 3,3′-diaminobenzidine
(DAB, Sigma) as a chromogenic substrate after 5 min.
Immunofluorescence staining of rFg14-3-3e protein bind-
ing to goat PBMCs
Freshly isolated goat PBMCs were incubated with rFg14-
3-3e protein for 1 h in a humidified atmosphere of 5%
CO2 at 37 °C. To minimize background staining, goat
PBMCs were fixed with 4% paraformaldehyde, washed 3
times in PBS (5 min each) and were treated with block-
ing solution (4% BSA in PBS) for 1 h at ambient
temperature. rFg14-3-3e-treated or non-treated control
goat PBMCs were incubated with rat anti-rFg14-3-3e
antibody (1:100) for 1 h at 37 °C, followed by staining
with Cy3 conjugated goat anti-rat IgG secondary anti-
body (1:500) (Beyotime, Haimen, Jiangsu, China) for 1 h
at 37°C. Hoechst 33342 (Invitrogen, Eugene, Oregon,
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USA) was used for nuclear staining. Stained cells were
imaged with 100× magnification using a Zeiss laser scan-
ning confocal microscope (LSM710, Zeiss, Jena,
Germany) and digital images were analyzed by Zen 2012
imaging software.
ELISA analysis of the levels of cytokines
Goat PBMCs were seeded into a 24-well tissue culture
plate at 106 cells/well in 1 ml medium consisting of
RPMI 1640 medium. Serial concentrations (10 μg/ml, 20
μg/ml, 40 μg/ml and 80 μg/ml) of rFg14-3-3e protein
were added to the wells. The sham-treated PBMCs
served as controls, and the plate was incubated in a hu-
midified atmosphere of 5% CO2 at 37 °C for 24 h. The
supernatants were collected, and assayed for cytokine
production using the goat enzyme linked immunosorb-
ent assay (ELISA) kits (Mlbio, Shanghai, China). Goat
PBMCs supernatants were assayed for the production of
interleukin-4 (IL-4), IL-10, interferon gamma (IFN-γ),
and transforming growth factor beta (TGF-β). Limits of
detection were between 2 and 800 pg/ml depending on
the analytic assay.
Inhibitory effect of rFg14-3-3e protein on cell
proliferation
Anti-proliferative effects of rFg14-3-3e protein on goat
PBMCs were determined by performing Cell Counting
Kit-8 (CCK-8) assay (Beyotime, Haimen, Jiangsu, China).
Goat PBMCs were seeded on 96-well tissue culture
plates (104 cells /well in 100 μl), with three replicates
used for each rFg14-3-3e protein concentration (10 μg/
ml, 20 μg/ml, 40 μg/ml, and 80 μg/ml). Cell cultured
plates were incubated at 37 °C in a humidified atmos-
phere with 5% CO2. Following 72 h incubation, 10 μl of
CCK-8 reagent was added to each well and the cultures
were further incubated at 37 °C in a humidified atmos-
phere of 5% CO2 at 37 °C for 4 h in the dark. The op-
tical density at 450 nm (OD450) was measured using a
microplate reader (Bio-Rad).
In vitro cell migration assay
Cell migration assay was performed using 6.5 mm
Transwell® with 8.0 μm-pore-size polyester membrane
inserts (Corning, Kennebunk, USA). Aliquots of 106 goat
PBMCs in 1 ml RPMI culture medium were placed into
the top chamber of the transwell in a 24-well tissue cul-
ture plate. Cells were stimulated with serial concentra-
tions of rFg14-3-3e protein and incubated in a
humidified atmosphere of 5% CO2 at 37 °C for 24 h.
After incubation, the cells were collected from the bot-
tom chamber and the number of cells that migrated
through the membrane into the lower chamber was de-
termined using Automated Cell Counter (Countstar,
Shanghai, China). The results were presented as percent-
ages of the seeded goat PBMCs.
Generation of nitric oxide
Nitric oxide production by goat PBMCs was evaluated
by measuring intracellular nitrite by Griess reaction fol-
lowing the protocol of Total Nitric Oxide Assay Kit
(Beyotime, Haimen, Jiangsu, China). Briefly, goat PBMCs
were seeded at 106 cells/well into a 24-well tissue culture
plate. Cells were incubated for 24 h with various concen-
trations of rFg14-3-3e protein in RPMI 1640 medium at
37 °C in a humidified atmosphere with 5% CO2. Absorb-
ance values of the colored solution were measured using
a plate microplate reader (Bio-Rad) at 540 nm. NO levels
were calculated against a standard curve generated using
0 to 80 μM/l sodium nitrites.
FITC-dextran uptake
The phagocytic activity of goat monocytes was assessed
by measuring the uptake of fluorescein isothiocyanate
(FITC)-dextran according to a previously described
method [33]. Briefly, freshly isolated goat monocytes
were seeded at 106 cells/well into a 24-well tissue culture
plate. Goat monocytes were incubated for 48 h with
various concentrations of rFg14-3-3e protein in RPMI
1640 medium in a humidified atmosphere of 5% CO2 at
37 °C. Then, goat monocytes were re-suspended in 100
μl of cold PBS, and incubated with 1 mg/ml FITC-
dextran (average molecular weight of dextran, 59,000 to
77,000; Sigma-Aldrich) in RPMI 1640 medium at 4 or
37 °C for 1 h. After incubation, chilled PBS containing
2% FBS was added to halt phagocytosis and then cells
were washed (three times with ice-cold PBS) and resus-
pended in ice-cold PBS containing 2% paraformalde-
hyde. FITC-dextran internalization of monocytes was
analyzed by flow cytometry (BD Biosciences, San Jose,
California, USA). Data were analyzed using FlowJo 10.1
software (Tree Star, Ashland, Oregon, USA). Goat
monocytes FITC-dextran (phagocytosis index) was cal-
culated as the change in Median Fluorescence Intensity
(MFI) between cell samples incubated at 37 °C and 4 °C.
Apoptosis assay using Annexin V/PI staining
Apoptosis in goat PBMCs was evaluated and quantified
by flow cytometry (BD Biosciences) using the Annexin
V-FITC kit (Miltenyi Biotec, Bergisch Gladbach,
Nordrhein-Westfalen, Germany). Briefly, PBMCs (106
cells/ml) were treated with different concentrations of
rFg14-3-3e protein and incubated in a humidified atmos-
phere of 5% CO2 at 37 °C for 24 h. Then, PBMCs were
stained with Annexin V and Propidium Iodide (PI) ac-
cording to the manufacturer’s instructions. The non-
treated goat PBMCs were used as a control. Annexin V-
positive/PI-negative goat PBMCs were considered to be
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apoptotic cells and were analyzed as a percentage of the
entire goat PBMCs population.
Homology modelling of rFg14-3-3e and potential com-
plexes with host proteins
Using protein blast [34] against the UniprotKB database
[35] we retrieved the most similar human protein of
rFg14-3-3e fasta protein sequence from uniprot. P62258
(YWHAE) had a Max score of 313, a Query coverage of
89% and 65% identity. Using P62258 (YWHAE), we
queried the following interactions databases: Intact [36],
String [37], BioPlex [38], BioGrid [39]. The resulting
interacting pairs were used as input for obtaining the ex-
perimental and homology modelled structure interac-
tions using Interactome3D [40]. All experimental and
modelled interactions were used to model potential
rFg14-3-3e-host interactions using FoldX [41]. The
alignment of the human YWHAE with rFg14-3-3e was
done using Clustal Omega [42]. Finally, a total energy
analysis was done to identify stabilized and destabilized
interactions. All complex structures and energy calcula-
tion files can be found in Additional file 1: Dataset S1.
Statistical analysis
All data analyses and graphs were performed with
GraphPad Premier 6.0 software package (GraphPad
Prism, San Diego, California, USA). Statistical analyses
were done from raw data with a one-way ANOVA, and
Student’s t-tests, where applicable. Data values were
expressed as means ± standard deviation (SD). Differ-
ences between tested groups were considered significant
if the P value was ≤ 0.05, and this is indicated in the fig-
ures by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001; or
****P < 0.0001). All experiments were repeated a mini-
mum of three separate times.
Results
Identification, cloning and expression of rFg14-3-3e
protein
To identify homologs of F. gigantica 14-3-3 protein in
the F. hepatica genome, we performed a BLAST search
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) to screen for
homologous 14-3-3 protein sequences. This analysis
identified Fh14-3-3e gene sequence (GenBank locus:
LN629113.1), which was used to design 5' and 3' primers
to amplify Fg14-3-3e. The Fg14-3-3e gene was amplified
and the cDNA fragment was successfully cloned into the
pMD19-T cloning vector.
Nucleic acid sequencing identified positive pMD19-T-
Fg14-3-3e clones and the obtained sequence was con-
firmed as Fg14-3-3e gene by BLAST analysis. The ORF
contained 774 base-pair (bp) and encoded 257 amino
acids. The SMART resource predicted the presence of a
14-3-3 domain encompassing residues 8–248, with an E-
value of 6.84e-132 (Fig. 1a). The sequence similarity
search showed that the 14-3-3 protein from F. hepatica
(PIS80765.1) is the protein with highest similarity (100%
identity, E-value 4e-170) (Fig. 1b). The best template
found by Swissmodel to predict the F. gigantica 3D
model was the protein 14-3-3 from Nicotiana tabacum
(PDB: 5nwk) with 58.2% of identity (Fig. 1c). There were
no N-linked glycosylation sites, signal peptides or trans-
membrane domains found in the deduced protein
sequence.
SDS-PAGE and Western blotting analysis
To verify the presence of the Fg14-3-3e protein in F.
gigantica parasite-derived material Fg14-3-3e gene frag-
ment was successfully cloned into the pPIC9K vector
and the positive clones, designated as pPIC9K-Fg14-3-3e,
Fig. 1 Characterization of the Fg14-3-3e sequence and the putative
domain. a The predicted 14-3-3 domain involved residues 8–248, with
an E-value of 6.84e-132. b Best Hit alignment of the Fg14-3-3e protein
sequence against the NCBI non-redundant protein sequence using
BLAST. The 14-3-3 protein from Fascicola hepatica (PIS80765.1) is the
protein with highest similarity (100% identity, E-value 4e-170) c The
predicted F. gigantica Fg14-3-3e 3D model shows 58.2% identity with
the protein 14-3-3 from Nicotiana tabacum (PDB: 5nwk)
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were transformed into P. pastoris strain GS115. The re-
combinant protein (rFg14-3-3e) was successfully
expressed in the culture supernatant of P. pastoris. The
recombinant clones showed high expression of a novel
protein of approximately 29 kDa on SDS-PAGE gels
(Fig. 2a) after 72 h of induction with 1% methanol,
which was absent in control samples. The specificity of
this rFg14-3-3e protein was confirmed by Western blot-
ting, which was probed with serum from goats experi-
mentally infected with F. gigantica. IgG antibodies in the
serum of infected goats recognized rFg14-3-3e protein
monospecifically as it reacted to a single ~29 kDa band,
which was absent when the Western blot was probed
with serum of normal goats and in the supernatant of P.
pastoris cells transformed with the pPIC9K vector with-
out the Fg14-3-3e insert (Fig. 2b).
Binding affinity of rFg14-3-3e protein to goat PBMCs
Binding of rFg14-3-3e protein to the surface of goat
PBMCs was assessed by immunofluorescent staining.
Tagging rFg14-3-3e-treated goat PBMCs with specific
rat anti-rFg14-3-3e antibodies, as indicated by the con-
centration of red Cy3 dye, showed successful binding of
rFg14-3-3e to the cell surface (Fig. 3), whereas, no fluor-
escence was observed in the non-treated cells.
rFg14-3-3e protein modulated cytokine production by
goat PBMCs
To gain insight into how rFg14-3-3e protein modulates
cytokine profiles of goat PBMCs, the levels of four cyto-
kines, IL-4, IL-10, IFN-γ, and TGF-β, were determined.
As shown in Fig. 4, when goat PBMCs were treated with
serial concentrations of rFg14-3-3e protein, the produc-
tion of IL-4 (10 μg/ml: ANOVA, F(4, 10) = 21.77, P =
0.0089; 20 μg/ml: ANOVA, F(4, 10) = 21.77, P = 0.0021;
40 μg/ml: ANOVA, F(4, 10) = 21.77, P = 0.0004; 80 μg/
ml: ANOVA, F(4, 10) = 21.77, P < 0.0001) and IFN-γ (10
μg/ml: ANOVA, F(4, 10) = 292.5, P = 0.5123; 20 μg/ml:
ANOVA, F(4, 10) = 292.5, P < 0.0001; 40 μg/ml: ANOVA,
F(4, 10) = 292.5, P < 0.0001; 80 μg/ml: ANOVA, F(4, 10) =
292.5, P < 0.0001) were significantly decreased compared
to the control goat PBMCs. On the other hand, the pro-
duction of IL-10 (10 μg/ml: ANOVA, F(4, 10) = 79.19, P
= 0.2803; 20 μg/ml: ANOVA, F(4, 10) = 79.19, P < 0.0001;
40 μg/ml: ANOVA, F(4, 10) = 79.19, P < 0.0001; 80 μg/
ml: ANOVA, F(4, 10) = 79.19, P < 0.0001) and TGF-β (10
μg/ml: ANOVA, F(4, 10) = 74.03, P = 0.0027; 20 μg/ml:
ANOVA, F(4, 10) = 74.03, P < 0.0001; 40 μg/ml: ANOVA,
F(4, 10) = 74.03, P < 0.0001; 80 μg/ml: ANOVA, F(4, 10) =
74.03, P < 0.0001) were increased.
rFg14-3-3e protein inhibited cell proliferation
To determine whether rFg14-3-3e protein has any influ-
ence on the proliferation of goat PBMCs, CCK-8 assay
was used. As shown in Fig. 5, the proliferation of goat
PBMCs was significantly inhibited following treatment
with rFg14-3-3e protein, at all tested protein concentra-
tions (10 μg/ml: ANOVA, F(4, 25) = 157.2, P < 0.0001; 20
μg/ml: ANOVA, F(4, 25) = 157.2, P < 0.0001; 40 μg/ml:
ANOVA, F(4, 25) = 157.2, P < 0.0001; 80 μg/ml: ANOVA,
F(4, 25) = 157.2, P < 0.0001). The anti-proliferative effect
of rFg14-3-3e protein was concentration-dependent.
rFg14-3-3e protein did not stimulate cell migration
Here, we tested whether rFg14-3-3e protein stimulates
the migration of goat PBMCs using 6.5 mm Transwell®
with 8.0 μm Pore Polyester Membrane Inserts. As shown
in Fig. 6, 40 μg/ml and 80 μg/ml of rFg14-3-3e protein
significantly suppressed the migration of goat PBMCs
compared with the controls, but the 10 μg/ml and 20
μg/ml did not (10 μg/ml: ANOVA, F(4, 10) = 361.4, P =
0.9902; 20 μg/ml: ANOVA, F(4, 10) = 361.4, P = 0.0011;
40 μg/ml: ANOVA, F(4, 10) = 361.4, P < 0.0001; 80 μg/
ml: ANOVA, F(4, 10) = 361.4, P < 0.0001).
Fig. 2 SDS-PAGE and Western blotting analyses of the extracted
rFg14-3-3e protein from the culture supernatant of P. pastoris. a
Proteins were resolved on 12% acrylamide gels and stained with
Coomassie brilliant blue R250. Lane M: protein molecular weight
marker in kDa; Lane P: purified recombinant protein, rFg14-3-3e,
which appeared as a single band of approximately 29 kDa
(arrow). b The protein of interest was run under non-reducing
conditions, and visualized by immunodetection using specific
antibodies and enhanced chemiluminescence. Lane M: protein
molecular weight marker in kDa; Lane P: loaded with recombinant
protein extracted from P. pastoris. Serum from F. gigantica-infected
goats detected a single band of approximately 29 kDa (arrow); Lane
C1: loaded with recombinant protein extracted from P. pastoris that
did not react with the serum of normal, pre-immunized, goats; Lane
C2: loaded with protein extracted from the supernatant of P. pastoris
cells transformed with the pPIC9K vector without Fg14-3-3e gene insert,
which did not react with goat serum containing anti-F. gigantica
IgG antibodies
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Nitric oxide production
As shown in Fig. 7, NO release was slightly increased by
goat PBMCs in the presence of rFg14-3-3e protein at 80
μg/ml dose compared to the control, but not at 10 μg/ml,
20 μg/ml or 40 μg/ml (10 μg/ml: ANOVA, F(4, 40) = 8.695,
P = 0.4307; 20 μg/ml: ANOVA, F(4, 40) = 8.695, P = 0.3221;
40 μg/ml: ANOVA, F(4, 40) = 8.695, P = 0.5012; 80 μg/ml:
ANOVA, F(4, 40) = 8.695, P = 0.0063). These results suggest
that increased NO production may become apparent only
with exposure to a larg rFg14-3-3e protein concentration.
Fig. 3 Fasciola gigantica-derived rFg14-3-3e protein binds to the surface of goat PBMCs. Visualization of rFg14-3-3e protein attachment to goat
PBMCs surface was carried out by incubation of goat PBMCs treated or untreated with rFg14-3-3e protein with rat anti-rFg14-3-3e primary
antibody. Hoechst (blue) and Cy3-conjugated secondary antibody (red) were used to stain host cell nuclei and rFg14-3-3e protein, respectively.
Surface staining was detected in rFg14-3-3e-treated cells. No staining was detectable in untreated cells. Scale-bars: 10 μm
Fig. 4 rFg14-3-3e protein induced polarized patterns of cytokine secretion. Goat PBMCs were incubated for 24 h in the presence or absence of
serial concentrations of rFg14-3-3e protein. The levels of cytokine concentration in the supernatant of cultured goat PBMCs was quantified by
ELISA. Graphs represent means ± standard deviations of data from 3 independent biological replicates. Asterisks indicate statistical significance
between treated and untreated control goat PBMCs (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, non-significant)
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rFg14-3-3e protein reduced cell phagocytosis
The phagocytic ability of goat monocytes was examined
via assessment of FITC-dextran uptake. Results revealed
that treatment with rFg14-3-3e protein at all tested pro-
tein concentrations suppressed goat monocyte phagocyt-
osis (10 μg/ml: ANOVA, F(4, 25) = 59.52, P < 0.0001; 20
μg/ml: ANOVA, F(4, 25) = 59.52, P < 0.0001; 40 μg/ml:
ANOVA, F(4, 25) = 59.52, P < 0.0001; 80 μg/ml: ANOVA,
F(4, 25) = 59.52, P < 0.0001) (Fig. 8). rFg14-3-3e protein
reduced FITC-dextran phagocytosis by approximately
32%, 42%, 65% and 70% at 10 μg/ml, 20 μg/ml, 40 μg/ml
and 80 μg/ml, respectively.
rFg14-3-3e protein stimulated cell apoptosis
To explore whether rFg14-3-3e protein has an apoptotic
effect on goat PBMCs, anenxin V-FITC/PI double stain-
ing apoptosis assay was used. The results showed that
Fig. 5 rFg14-3-3e protein inhibited goat PBMCs proliferation.
Goat PBMCs were sham-treated with control buffer or with serial
concentrations of rFg14-3-3e protein and incubated for 72 h at
37 °C at 5% CO2. Proliferation of cells was determined using CCK-8 assay.
Results indicate that rFg14-3-3e protein significantly inhibited goat
PBMCs proliferation. Graphs represent means ± standard deviations of
data from 3 independent biological replicates. Asterisks indicate
significance difference between treated cells and control cells
(****P < 0.0001)
Fig. 6 rFg14-3-3e protein suppressed goat PBMCs migration.
Goat PBMCs were sham-treated with control buffer or with serial
concentrations of rFg14-3-3e protein, then the cell migration percentage
(%) was determined. Graphs represent means ± standard deviations of
data from 3 independent biological replicates. The asterisks indicate
significant difference between treated and sham-treated control cells
(**P < 0.001; ****P < 0.0001; ns, non-significant)
Fig. 7 Effects of rFg14-3-3e protein on intracellular NO production.
Goat PBMCs were sham-treated with control buffer or with serial
concentrations of rFg14-3-3e protein and maintained at 37 °C. NO
concentration in the goat PBMCs was measured by Griess assay. Graphs
represent means ± standard deviations of data from 3 independent
biological replicates. Asterisks indicate significant difference between
treated and non-treated control cells (**P < 0.01; ns, non-significant).
The inhibitory effect was only statistically significant at the highest
concentration (80 μm/ml)
Fig. 8 rFg14-3-3e protein suppressed goat cell phagocytosis.
rFg14-3-3e protein inhibited the phagocytic ability of monocytes
as indicated by the reduction in FITC-dextran uptake in a dose-
dependent manner. Graphs represent means ± standard deviations
of data from 3 independent biological replicates. Significance was
set at ****P < 0.0001 compared to sham-treated monocytes
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rFg14-3-3e protein significantly induced, in a dose-
dependent manner, apoptosis in goat PBMCs at all
tested concentrations compared to untreated control
goat PBMCs (10 μg/ml: ANOVA, F(4, 37) = 104.4, P <
0.0001; 20 μg/ml: ANOVA, F(4, 37) = 104.4, P < 0.0001;
40 μg/ml: ANOVA, F(4, 37) = 104.4, P < 0.0001; 80 μg/
ml: ANOVA, F(4, 37) = 104.4, P < 0.0001) (Fig. 9).
Modelled protein interactions suggest host interacting
partners of the rFg14-3-3e protein
We performed homology modelling using the human
14-3-3 protein YWHAE, which had 65% identity to the
rFg14-3-3e using FoldX (Fig. 10). We then used Interac-
tome3D [40] to model protein complexes involving
YWHAE and its human interactors. Interactome3D re-
trieved 52 complex models between P62258 and other
18 human proteins. Multiple models were made per
complex based on different complex templates that were
available in the PDB [43]. We then used FoldX [41] to
model the interaction between the rFg14-3-3e and these
human proteins, and to calculate the changes in free en-
ergy for these complexes. Additional file 2: Table S1
shows the list of interactions with its respective total en-
ergy for the human YWHAE protein and the modelled
rFg14-3-3e protein, and the difference of the previous
values. More negative energy values for the rFg14-3-3e
compared to the human YWHAE indicate increased
complex stability, and may suggest potential interactors
of the parasite protein in the host. Positive energy values
indicate unstable complexes and thus unfavorable inter-
actions. We observed negative values for 13 out of the
18 potentially interacting proteins. Enrichment analysis
of the interacting proteins using Funcassociate 3.0 [44]
identified Gene Ontology (GO) terms related to apop-
tosis, protein binding, locomotion, hippo signalling and
Fig. 9 rFg14-3-3e protein induced apoptosis in goat PBMCs. Apoptotic cells were determined by Annexin V/PI staining and flow cytometry
analysis. a Dot plot showing death of goat PBMCs in response to exposure to rFg14-3-3e protein. b Apoptotic cells (Annexin V+/PI-) were plotted
and compared with percentage of cell population. Graphs represent means ± standard deviations of data from 3 independent biological replicates.
The asterisks indicate significant differences between treated and untreated control goat PBMCs (****P < 0.0001)
Fig. 10 3D visualization of the rFg14-3-3e molecule. Molecular homology
modelling using FoldX was used to predict a three-dimensional
representation of the rFg14-3-3e protein. The predicted rFg14-3-3e
3D model shows 65% identity with the human 14-3-3 protein YWHAE
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leukocyte, and lymphocyte differentiation (Additional file
3: Table S2).
Discussion
Here, Fg14-3-3e gene was successfully cloned, expressed
and the recombinant protein (rFg14-3-3e) was obtained.
Sequence analysis of this recombinant protein indicated
that rFg14-3-3e protein is a member of the 14-3-3 fam-
ily, which mediates metabolism and signal transduction
networks through binding to hundreds of other protein
partners [15, 18–20]. The 14-3-3 protein has been stud-
ied in other parasitic helminths [45] and Fh14-3-3e pro-
tein was able to bind to goat PBMCs in vivo [46].
The aim of the present study was to investigate the
immunomodulatory effects of rFg14-3-3e protein on
goat innate immunity. To achieve this, we cloned and
expressed Fg14-3-3 protein in a heterologous system.
Our results demonstrated the successful expression of
rFg14-3-3e with a molecular mass of approximately
29kDa, which was validated by Western blotting using
sera from F. gigantica-experimentally-infected goats.
This rFg14-3-3e protein also reacted with the rat anti-
rFg14-3-3e antibodies as indicated by specific binding of
rFg14-3-3e protein to the surface of goat PBMCs, sug-
gesting that rFg14-3-3e protein might be involved in
interaction with cellular elements of the innate immune
system during F. gigantica infection in goats. This im-
munogenicity of rFg14-3-3e protein makes it a good
candidate for the development of a diagnostic assay for
F. gigantica infection.
Our data also showed that goat PBMCs exposed to
rFg14-3-3e protein change their cytokine production
profile and undergo apoptosis in vitro. In particular,
rFg14-3-3e-induced the production of IL-10 and TGF-β,
while reduced the production of IL-4 and IFN-γ, sug-
gesting that rFg14-3-3e protein has polarized the goat
PBMCs’ immune cytokine pattern. Earlier studies indi-
cated that apoptotic cells may be involved in suppressing
inflammatory responses by inducing the anti-
inflammatory cytokines, IL-10 [47, 48] and TGF-β [49,
50]. IL-10 and TGF-β secreted by allergen-specific type
1 regulatory (Tr1) cells were found to cause immuno-
suppression via inhibition of T-cell activation and differ-
entiation [51]. Therefore, both IL-10 and TGF-β
cytokines released from apoptotic goat PBMCs are likely
to modulate immune-inflammatory responses during F.
gigantica infection.
Our observation that rFg14-3-3e protein suppresses
immune response is in line with what we described pre-
viously during F. gigantica infection in buffaloes. An
‘early’ TGF-β-associated immuno-suppressive response
together with upregulation of liver IL-10 mRNA expres-
sion [52] and increased level of serum IL-10 cytokine
[53] have been observed in buffaloes during early F.
gigantica infection. In another study, we reported down-
regulation of MHC-II related genes and suppression of
the host pro-inflammatory (Th1) immune response dur-
ing early F. gigantica infection in buffalo liver [54]. This
observation extends to F. hepatica, where immunosup-
pression, mediated by IL-4 and IL-10, was reported in
experimentally infected rats during the early stage of
liver penetration [55]. In the context of F. gigantica in-
fection, suppression of immune response may have
beneficial effects in terms of promoting parasite survival,
while minimizing the inflammatory pathological damage
in the host.
We subsequently showed that rFg14-3-3e protein sig-
nificantly inhibited the proliferation and migration of
treated goat PBMCs compared to untreated cells. Prolif-
eration and migration of host immune cells and produc-
tion of cytokines are essential for the control of parasite
infection [56, 57]. Also, we found that rFg14-3-3e pro-
tein inhibits the phagocytic activity of monocytes, and
increases the NO release only at a high concentration.
The abomasal nematode Haemonchus contortus was also
found to inhibit phagocytosis, production of NO and
free radicals of host monocytes [58]. These previous re-
sults and our findings indicate that similar to14-3-3 pro-
tein of other parasites, rFg14-3-3e protein can actively
suppress host monocyte phagocytosis, and inhibits the
proliferation and migration of treated goat PBMCs to
promote the survival of the parasite.
Next, we detected a significantly high degree of rFg14-
3-3e-induced apoptosis in goat PBMCs. 14-3-3 proteins
are key regulators of protein kinase signaling cascades
and can play many roles in apoptosis, signal transduc-
tion, and cell cycle regulation [59, 60]. Induction of
apoptosis has also been reported in the peritoneal leuco-
cytes of sheep experimentally infected with F. hepatica
during early infection in an effort to support the juvenile
flukes’ survival during the peritoneal migration to the
liver [61]. Transcriptomic analysis showed that F. hepat-
ica may attenuate the inflammatory response through
induction of apoptosis in goat PBMCs [62]. Therefore, it
can be assumed that reduced proliferation and increased
apoptosis of goat PBMCs in response to exposure to
rFg14-3-3e may be survival mechanisms used by F.
gigantica to evade host immune defence mechanisms.
Both the death receptor pathway (extrinsic) and the
mitochondrial pathway (intrinsic) seemed to contribute
to F. hepatica-induced apoptosis in goat PBMCs [62].
However, apoptotic mechanisms vary in response to dif-
ferent parasite species or host cell types. Therefore, fur-
ther studies are required to investigate the process by
which rFg14-3-3e protein causes death of goat PBMCs.
The knowledge of the 3D structure of rFg14-3-3e pro-
tein can help in the understanding of its function and
knowledge of the extent of molecular interaction
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between this protein and other host proteins may help
in future design of novel molecules useful to modulate
its activity. In our work, we predicted the three-
dimensional model of the homo-dimer using homology
modelling (Swissmodel). This prediction strategy identi-
fied the protein 14-3-3 from Nicotiana tabacum (PDB:
5nwk) as the best template to predict the F. gigantica 3D
model with 58.2% identity. We were also interested in
studying potential host protein interactors with rFg14-3-
3e protein. Therefore, we searched the UniprotKB data-
base in order to identify a human protein that has the
highest similarity to rFg14-3-3e fasta protein sequence.
This analysis revealed 65% identity between rFg14-3-3e
and human P62258 (YWHAE). Human YWHAE gene
codes for 14-3-3 protein epsilon, which is implicated in
the regulation of a large spectrum of signaling pathways.
YWHAE was used as input to identify potential interac-
tions of YWHAE protein with other human proteins in
various interaction databases. The interacting pairs were
then used to obtain experimental and homology mod-
elled structure interactions using Interactome3D. All
identified experimental and modelled interactions were
used to model potential rFg14-3-3e-host interactions
using FoldX. The majority (13 of the 18) of the poten-
tially interacting proteins of rFg14-3-3e compared to the
human YWHAE were negative, suggesting more inter-
connectivity of the parasite protein with the host pro-
tein. We also, performed GO enrichment analysis, which
identified terms related to apoptosis, protein binding,
locomotion, hippo signaling, and leukocyte and lympho-
cyte differentiation, all critical pieces of the immuno-
pathogenesis of F. gigantica infection. These findings
indicate that results obtained by in silico analysis sup-
port the reliability of the experimental findings and dem-
onstrate that rFg14-3-3e is involved in a number of
immunoregulatory activities.
Conclusions
The results obtained in this study showed clear modula-
tory effects of rFg14-3-3e protein on multiple functions
of goat PBMCs in vitro. rFg14-3-3e protein interacted
with sera from goats experimentally infected with F.
gigantica and with rat anti-rFg14-3-3e antibody. Also,
rFg14-3-3e protein stimulated the concurrent produc-
tion of IL-10 and TGF-β, and promoted apoptosis of
goat PBMCs. In addition, rFg14-3-3e protein reduced
the production of IL-4 and IFN-γ, inhibited proliferation
and migration of goat PBMCs, and suppressed monocyte
phagocytic ability. Results obtained from experimental
studies were supported by homology modelling and GO
enrichment analysis. These findings indicate that F.
gigantica rFg14-3-3e protein, may play important roles
in the interaction of F. gigantica with goat PBMCs. Our
data may lead to a better understanding of F. gigantica
interactions with goat PBMCs and fasciolosis pathogen-
esis. These results may be relevant for the identification
of potential novel immunomodulatory therapies and pre-
ventative strategies, since antibodies or chemical inhibi-
tors against rFg14-3-3e protein can interfere with
important mechanisms in parasite survival. Further stud-
ies are warranted to determine the immunomodulatory
role of rFg14-3-3e protein in the context of F. gigantica
infection in goats.
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